• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Yu.Research on strategies for balancing authority and communication reach in government new media for drug regulation: A case study of "Chinese Pharmaceutical News"[J].Journal Of Pharmaceutical Research,2026,45(9):1013-1017,1071[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 231times   Download 196次 QR Code for this article
Scan with your phone!
药品监管政务新媒体的权威性与传播力平衡策略研究——以“中国药闻”为例
张宇
Font:Larger+|Default|Smaller-
(国家药品监督管理局新闻宣传中心,北京 100037)
摘要:
新时代以来,我国药品监管政务新媒体建设在取得一定成果的同时,也面临着权威性与传播力难以兼容的二元困境,从根本上限制了药品监管政务新媒体的长远发展。针对这一问题,以“中国药闻”为典型的药品监管政务新媒体品牌,通过构建“平台差异化布局、系统层级化联动、分众化传播”的三维传播体系,达成了行政与社会资源的有效整合、权威信息的广泛传播以及科普知识的精准触达,探寻出一条解决上述困境的实践路径,为提升药品监管传播效能提供了经验参考。
关键词:  药品监管  政务新媒体  中国药闻  传播矩阵
DOI:10.13506/j.cnki.jpr.2026.09.008
基金项目:
Received Date:May 29, 2026   Revision Date:July 20, 2026   Publication Date:September 30, 2026
Research on strategies for balancing authority and communication reach in government new media for drug regulation: A case study of "Chinese Pharmaceutical News"
ZHANG Yu
(News and Publicity Center,National Medical Products Administration,Beijing 100037,China)
Abstract:
Ever since the new era started, China has made significant progress in the development of government new media for drug regulation. These platforms continue to face a structural dilemma in which authority and communication reach are often difficult to reconcile. This kind of tension fundamentally limits the sustainable growth of government new media in the drug regulation area. In response to this challenge, government new media brands for drug regulation, represented by "Chinese Pharmaceutical News", have developed a three-dimensional communication system featuring differentiated platform deployment, hierarchical system-wide coordination, and audience-oriented integrated communication. This system has effectively integrated administrative and social resources, expanded the dissemination of authoritative information, and enabled the precise delivery of science popularization content. It offers a practical pathway for resolving the tension between authority and communication reach and provides useful experience for improving the effectiveness of pharmaceutical regulatory communication.
Key words:  Drug regulation  Government new media  Chinese Pharmaceutical News  Communication matrix
Today's Visits:447    Total Visits:2383131
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.